Clinical Trials List
2024-01-01 - 2025-12-31
Phase I
Recruiting1
ICD-10D70.0
Congenital agranulocytosis
ICD-10D70.1
Agranulocytosis secondary to cancer chemotherapy
ICD-10D70.2
Other drug-induced agranulocytosis
ICD-10D70.3
Neutropenia due to infection
ICD-10D70.4
Cyclic neutropenia
ICD-10D70.8
Other neutropenia
ICD-10D70.9
Neutropenia, unspecified
ICD-10D72.819
Decreased white blood cell count, unspecified
ICD-10D73.81
Neutropenic splenomegaly
ICD-10D76.1
Hemophagocytic lymphohistiocytosis
ICD-10D76.2
Hemophagocytic syndrome, infection-associated
ICD-10D76.3
Other histiocytosis syndromes
ICD-9288.0
Agranulocytosis
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
30 participants
